Literature DB >> 36041004

Feasibility of At-Home Serial Testing Using Over-the-Counter SARS-CoV-2 Tests With a Digital Smartphone App for Assistance: Longitudinal Cohort Study.

Carly Herbert1, John Broach2,3, William Heetderks4, Felicia Qashu5, Laura Gibson6, Caitlin Pretz1, Kelsey Woods1, Vik Kheterpal7, Thejas Suvarna7, Christopher Nowak7, Peter Lazar8, Didem Ayturk8, Bruce Barton8, Chad Achenbach9, Robert Murphy9, David McManus1,10, Apurv Soni1,8.   

Abstract

BACKGROUND: The ongoing SARS-CoV-2 pandemic necessitates the development of accurate, rapid, and affordable diagnostics to help curb disease transmission, morbidity, and mortality. Rapid antigen tests are important tools for scaling up testing for SARS-CoV-2; however, little is known about individuals' use of rapid antigen tests at home and how to facilitate the user experience.
OBJECTIVE: This study aimed to describe the feasibility and acceptability of serial self-testing with rapid antigen tests for SARS-CoV-2, including need for assistance and the reliability of self-interpretation.
METHODS: A total of 206 adults in the United States with smartphones were enrolled in this single-arm feasibility study in February and March 2021. All participants were asked to self-test for COVID-19 at home using rapid antigen tests daily for 14 days and use a smartphone app for testing assistance and to report their results. The main outcomes were adherence to the testing schedule, the acceptability of testing and smartphone app experiences, and the reliability of participants versus study team's interpretation of test results. Descriptive statistics were used to report the acceptability, adherence, overall rating, and experience of using the at-home test and MyDataHelps app. The usability, acceptability, adherence, and quality of at-home testing were analyzed across different sociodemographic, age, and educational attainment groups.
RESULTS: Of the 206 enrolled participants, 189 (91.7%) and 159 (77.2%) completed testing and follow-up surveys, respectively. In total, 51.3% (97/189) of study participants were women, the average age was 40.7 years, 34.4% (65/189) were non-White, and 82% (155/189) had a bachelor's degree or higher. Most (n=133/206, 64.6%) participants showed high testing adherence, meaning they completed over 75% of the assigned tests. Participants' interpretations of test results demonstrated high agreement (2106/2130, 98.9%) with the study verified results, with a κ score of 0.29 (P<.001). Participants reported high satisfaction with self-testing and the smartphone app, with 98.7% (157/159) reporting that they would recommend the self-test and smartphone app to others. These results were consistent across age, race/ethnicity, and gender.
CONCLUSIONS: Participants' high adherence to the recommended testing schedule, significant reliability between participants and study staff's test interpretation, and the acceptability of the smartphone app and self-test indicate that self-tests for SARS-CoV-2 with a smartphone app for assistance and reporting is a highly feasible testing modality among a diverse population of adults in the United States. ©Carly Herbert, John Broach, William Heetderks, Felicia Qashu, Laura Gibson, Caitlin Pretz, Kelsey Woods, Vik Kheterpal, Thejas Suvarna, Christopher Nowak, Peter Lazar, Didem Ayturk, Bruce Barton, Chad Achenbach, Robert Murphy, David McManus, Apurv Soni. Originally published in JMIR Formative Research (https://formative.jmir.org), 18.10.2022.

Entities:  

Keywords:  COVID-19; MyDataHelps smartphone app; SARS-CoV-2; digital health; mHealth; mobile health; pandemic; rapid tests; self test; serial self-testing

Year:  2022        PMID: 36041004      PMCID: PMC9580993          DOI: 10.2196/35426

Source DB:  PubMed          Journal:  JMIR Form Res        ISSN: 2561-326X


  24 in total

1.  Assessing How Consumers Interpret and Act on Results From At-Home COVID-19 Self-test Kits: A Randomized Clinical Trial.

Authors:  Steven Woloshin; Barry Dewitt; Tamar Krishnamurti; Baruch Fischhoff
Journal:  JAMA Intern Med       Date:  2022-03-01       Impact factor: 44.409

2.  Racial and ethnic inequities in the early distribution of U.S. COVID-19 testing sites and mortality.

Authors:  Nathan P Dalva-Baird; Wilson M Alobuia; Eran Bendavid; Jay Bhattacharya
Journal:  Eur J Clin Invest       Date:  2021-08-27       Impact factor: 5.722

3.  The Lines That Held Us: Assessing Racial and Socioeconomic Disparities in SARS-CoV-2 Testing.

Authors:  Chu J Hsiao; Aditi G M Patel; Henrietta O Fasanya; Michelle R Stoffel; Stacy G Beal; Gabrielle N Winston-McPherson; Sean T Campbell; Steven W Cotten; Bridgit O Crews; Kevin Kuan; Cathryn J Lapedis; Patrick C Mathias; Octavia M Peck Palmer; Dina N Greene
Journal:  J Appl Lab Med       Date:  2021-07-08

4.  A Geography of Risk: Structural Racism and Coronavirus Disease 2019 Mortality in the United States.

Authors:  Lauren C Zalla; Chantel L Martin; Jessie K Edwards; Danielle R Gartner; Grace A Noppert
Journal:  Am J Epidemiol       Date:  2021-08-01       Impact factor: 4.897

5.  Is Covid-19 community level testing effective in reaching at-risk populations? Evidence from spatial analysis of New Orleans patient data at walk-up sites.

Authors:  Julie H Hernandez; Dimitris Karletsos; Jennifer Avegno; Chantell H Reed
Journal:  BMC Public Health       Date:  2021-04-01       Impact factor: 3.295

6.  Spatial Inequities in COVID-19 Testing, Positivity, Confirmed Cases, and Mortality in 3 U.S. Cities : An Ecological Study.

Authors:  Usama Bilal; Loni P Tabb; Sharrelle Barber; Ana V Diez Roux
Journal:  Ann Intern Med       Date:  2021-03-30       Impact factor: 25.391

7.  Racial Segregation, Testing Site Access, and COVID-19 Incidence Rate in Massachusetts, USA.

Authors:  Tao Hu; Han Yue; Changzhen Wang; Bing She; Xinyue Ye; Regina Liu; Xinyan Zhu; Weihe Wendy Guan; Shuming Bao
Journal:  Int J Environ Res Public Health       Date:  2020-12-19       Impact factor: 3.390

8.  Diagnostic performance, user acceptability, and safety of unsupervised SARS-CoV-2 rapid antigen-detecting tests performed at home.

Authors:  Ida Johanne B Møller; Amalie R Utke; Ulla K Rysgaard; Lars J Østergaard; Sanne Jespersen
Journal:  Int J Infect Dis       Date:  2022-01-14       Impact factor: 12.074

9.  A mixed methods study evaluating acceptability of a daily COVID-19 testing regimen with a mobile-app connected, at-home, rapid antigen test: Implications for current and future pandemics.

Authors:  Nadia Nguyen; Benjamin Lane; Sangwon Lee; Sharon Lipsky Gorman; Yumeng Wu; Alicia Li; Helen Lu; Noemie Elhadad; Michael Yin; Kathrine Meyers
Journal:  PLoS One       Date:  2022-08-08       Impact factor: 3.752

10.  Design and Preliminary Findings of Adherence to the Self-Testing for Our Protection From COVID-19 (STOP COVID-19) Risk-Based Testing Protocol: Prospective Digital Study.

Authors:  Carly Herbert; Vik Kheterpal; Thejas Suvarna; John Broach; Juan Luis Marquez; Ben Gerber; Summer Schrader; Christopher Nowak; Emma Harman; William Heetderks; Nisha Fahey; Elizabeth Orvek; Peter Lazar; Julia Ferranto; Kamran Noorishirazi; Shivakumar Valpady; Qiming Shi; Honghuang Lin; Kathryn Marvel; Laura Gibson; Bruce Barton; Stephenie Lemon; Nathaniel Hafer; David McManus; Apurv Soni
Journal:  JMIR Form Res       Date:  2022-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.